These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 10402474

  • 1. IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity.
    Shiraha H, Glading A, Gupta K, Wells A.
    J Cell Biol; 1999 Jul 12; 146(1):243-54. PubMed ID: 10402474
    [Abstract] [Full Text] [Related]

  • 2. Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain.
    Shiraha H, Glading A, Chou J, Jia Z, Wells A.
    Mol Cell Biol; 2002 Apr 12; 22(8):2716-27. PubMed ID: 11909964
    [Abstract] [Full Text] [Related]

  • 3. Glu-Leu-Arg-negative CXC chemokine interferon gamma inducible protein-9 as a mediator of epidermal-dermal communication during wound repair.
    Satish L, Yager D, Wells A.
    J Invest Dermatol; 2003 Jun 12; 120(6):1110-7. PubMed ID: 12787142
    [Abstract] [Full Text] [Related]

  • 4. Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain.
    Satish L, Blair HC, Glading A, Wells A.
    Mol Cell Biol; 2005 Mar 12; 25(5):1922-41. PubMed ID: 15713646
    [Abstract] [Full Text] [Related]

  • 5. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement.
    Chen P, Xie H, Sekar MC, Gupta K, Wells A.
    J Cell Biol; 1994 Nov 12; 127(3):847-57. PubMed ID: 7962064
    [Abstract] [Full Text] [Related]

  • 6. IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain.
    Bodnar RJ, Yates CC, Wells A.
    Circ Res; 2006 Mar 17; 98(5):617-25. PubMed ID: 16484616
    [Abstract] [Full Text] [Related]

  • 7. m-Calpain activation is regulated by its membrane localization and by its binding to phosphatidylinositol 4,5-bisphosphate.
    Leloup L, Shao H, Bae YH, Deasy B, Stolz D, Roy P, Wells A.
    J Biol Chem; 2010 Oct 22; 285(43):33549-33566. PubMed ID: 20729206
    [Abstract] [Full Text] [Related]

  • 8. EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCgamma signaling pathway.
    Xie H, Pallero MA, Gupta K, Chang P, Ware MF, Witke W, Kwiatkowski DJ, Lauffenburger DA, Murphy-Ullrich JE, Wells A.
    J Cell Sci; 1998 Mar 22; 111 ( Pt 5)():615-24. PubMed ID: 9454735
    [Abstract] [Full Text] [Related]

  • 9. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
    Lowe WL, Fu R, Banko M.
    Endocrinology; 1997 Jun 22; 138(6):2219-26. PubMed ID: 9165004
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of EGF-dependent mitogenesis by prostaglandin E2 in Syrian hamster embryo fibroblasts.
    Hsi LC, Eling TE.
    Prostaglandins Leukot Essent Fatty Acids; 1998 Apr 22; 58(4):271-81. PubMed ID: 9654400
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway.
    Glading A, Chang P, Lauffenburger DA, Wells A.
    J Biol Chem; 2000 Jan 28; 275(4):2390-8. PubMed ID: 10644690
    [Abstract] [Full Text] [Related]

  • 12. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor.
    Swindle CS, Tran KT, Johnson TD, Banerjee P, Mayes AM, Griffith L, Wells A.
    J Cell Biol; 2001 Jul 23; 154(2):459-68. PubMed ID: 11470832
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway.
    Iwabu A, Smith K, Allen FD, Lauffenburger DA, Wells A.
    J Biol Chem; 2004 Apr 09; 279(15):14551-60. PubMed ID: 14747473
    [Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor-like repeats of thrombospondins activate phospholipase Cgamma and increase epithelial cell migration through indirect epidermal growth factor receptor activation.
    Liu A, Garg P, Yang S, Gong P, Pallero MA, Annis DS, Liu Y, Passaniti A, Mann D, Mosher DF, Murphy-Ullrich JE, Goldblum SE.
    J Biol Chem; 2009 Mar 06; 284(10):6389-402. PubMed ID: 19129184
    [Abstract] [Full Text] [Related]

  • 15. Phosphorylation of alpha-actinin 4 upon epidermal growth factor exposure regulates its interaction with actin.
    Shao H, Wu C, Wells A.
    J Biol Chem; 2010 Jan 22; 285(4):2591-600. PubMed ID: 19920151
    [Abstract] [Full Text] [Related]

  • 16. Spatial localization of m-calpain to the plasma membrane by phosphoinositide biphosphate binding during epidermal growth factor receptor-mediated activation.
    Shao H, Chou J, Baty CJ, Burke NA, Watkins SC, Stolz DB, Wells A.
    Mol Cell Biol; 2006 Jul 22; 26(14):5481-96. PubMed ID: 16809781
    [Abstract] [Full Text] [Related]

  • 17. Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling.
    Glading A, Uberall F, Keyse SM, Lauffenburger DA, Wells A.
    J Biol Chem; 2001 Jun 29; 276(26):23341-8. PubMed ID: 11319218
    [Abstract] [Full Text] [Related]

  • 18. Lysophosphatidic acid inhibits Ca2+ signaling in response to epidermal growth factor receptor stimulation in human astrocytoma cells by a mechanism involving phospholipase C(gamma) and a G(alphai) protein.
    Hernández M, Barrero MJ, Crespo MS, Nieto ML.
    J Neurochem; 2000 Oct 29; 75(4):1575-82. PubMed ID: 10987838
    [Abstract] [Full Text] [Related]

  • 19. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
    Putz T, Culig Z, Eder IE, Nessler-Menardi C, Bartsch G, Grunicke H, Uberall F, Klocker H.
    Cancer Res; 1999 Jan 01; 59(1):227-33. PubMed ID: 9892211
    [Abstract] [Full Text] [Related]

  • 20. Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors.
    Shiraha H, Gupta K, Drabik K, Wells A.
    J Biol Chem; 2000 Jun 23; 275(25):19343-51. PubMed ID: 10764734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.